The future of longevity is no longer science fiction. Ultra-wealthy investors and elite clients are spending millions on cutting-edge gene therapies to slow aging, repair DNA, and extend human lifespan. In Resilient Alpha Future of Longevity, we explore why longevity biotech is attracting massive private capital, how gene therapy investments work, and what this trend signals for hea... https://youtube.com/shorts/1mofxC7glUk?si=6_KRy4FqHlHVsqEI